NXGL.NASDAQNexgel, INC

Form 4: NEXGEL CEO Adam R. Levy Sells 4,000 Shares for Tax Planning

Sentiment:

SEC Form 4


NEXGEL's CEO, Adam R. Levy, sold 4,000 shares of common stock on March 3, 2025, at an average price of $3.1597 per share, as part of a pre-arranged Rule 10b5-1 trading plan for tax planning purposes.

Summary

  • On March 3, 2025, Adam R. Levy, the CEO of NEXGEL, Inc., sold 4,000 shares of the company's common stock.
  • The sale was executed at a weighted average price of $3.1597 per share, with individual transactions ranging from $3.0800 to $3.1700.
  • The transaction was conducted under a Rule 10b5-1 trading plan, which was established for tax planning purposes.
  • Following the reported transaction, Levy directly owns 374,284 shares of NEXGEL common stock.
  • The shares sold were originally acquired by Levy on October 15, 2019, and were not part of recent registered direct offerings by NEXGEL.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a routine disclosure of an insider stock sale under a pre-arranged plan.

Industry Context

This is a routine disclosure of an insider stock sale. It's common for executives to sell shares for personal financial planning, including tax purposes. The use of a 10b5-1 plan suggests the sales were pre-planned and not based on inside information.

Stakeholder Impact

  • The sale could have a minor negative impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider information.

Key Dates

DateDescription
2019-10-15Date the shares sold were originally acquired by Adam R. Levy
2025-03-03Date of the stock sale transaction
2025-03-05Date of the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.